Anat Loewestein

32PUBLICATIONS
48CO-AUTHORS
Optical technologyMajor global burdens of diseaseRegenerative medicine (incl. stem cells)Gene and molecular therapyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 07, 2026
Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice.

|Dec 31, 2025
Home Monitoring for the Management of Age-Related Macular Degeneration: A Review of the Development and Implementation of Digital Health Solutions over a 25-Year Scientific Journey.

Miguel A Busquets, Richard A Garfinkel, Deepak Sambhara

|Mar 03, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study.

Ashish Sharma, Frank G Holz, Nilesh Kumar

|Feb 19, 2025
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally.

Ashish Sharma, Se Joon Woo, Christopher Seungkyu Lee

|Jan 08, 2025
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy.

David Rabinovitch, Shiri Shulman, Dafna Goldenberg

|Dec 19, 2024
Reply.

Elad Moisseiev, Anat Loewenstein

Pageof 6

Frequent Collaborators

9 joint publications

Ashish Sharma

7 joint publications

Francesco Bandello

7 joint publications

Nilesh Kumar

4 joint publications

Javier Zarranz-Ventura